The company says the interim data from the MAGIC-G1 study has raised hopes that MTX110 could provide a new treatment option. A phase 1 study conducted by UCSF involved pediatric brain cancer ...
I’m one of the consumer PC experts at PCMag, with a particular love for PC gaming. I've played games on my computer for as long as I can remember, which eventually (as it does for many) led me ...
More than six years have passed since the globetrotting Extravagant Kid brought his best to win the Lucky Coin at Saratoga Race Course, but the talented son of Kiss the Kid has not strayed far ...
“The interim data from the MAGIC-G1 study has raised hopes that MTX110 could provide a new treatment option that offers real benefits in survival without the toxicity associated with traditional ...
Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma Cohort A Data on Overall Survival Compare Favorably with Published Survival ...
In October 2023, the Company announced completed recruitment of four patients into cohort A of its Phase 1 study of MTX110 (also known as MAGIC-G1 study)(NCT 05324501) in patients with recurrent ...